Prof. Fernando López-Ríos (NTRK CONNECT) has developed this resource with COR2ED.
Prof. Fernando López-Ríos (NTRK CONNECT) has developed this resource with COR2ED.
Fernando Lopez-Rios is the Chief of the Molecular Diagnostics Service at Hospital Universitario 12 de Octubre (Madrid) and Professor of Pathology at Universidad Complutense (Madrid).
Dr Lopez-Rios has also been the Director of the Therapeutic Targets Laboratory at HM Hospitales (Spain) and a visiting researcher at Memorial Sloan Kettering Cancer Center (New York).
He is the 2023 recipient of the Mary J. Matthews Pathology & Transitional Research Award (International Association for the Study of Lung Cancer, IASLC) and the Deputy Chair of the IASLC Pathology Committee.
His main clinical and research expertise is in cancer biomarker testing.
AstraZeneca, Bayer, BMS, Lilly, MSD, Pfizer, Roche, Takeda and Thermo Fisher.
A medical oncologist and a patient advocate share their perspectives
Clinical insights and expert discussion
Experts join us at ESMO 2025 to share their views on new data on GU, lung, breast, gynecological and upper GI cancers
PRRT and emerging strategies in neuroendocrine tumours
Early treatment intensification with a PARPi plus ARPI combination
Expert insights on the latest data in oncogene-addicted non-small cell lung cancer